Effectiveness of the Strengthening Families Program (SFP10-14) for reducing alcohol and drug misuse amongst youth in Poland

ISRCTN	ISRCTN89673828
DOI	https://doi.org/10.1186/ISRCTN89673828
Protocol serial number	N/A
Sponsor	Institute of Psychiatry and Neurology (Poland)
Funders	Polish Bureau for Drug Prevention (Poland), Diageo PLC

Submission date: 05/03/2011
Registration date: 17/03/2011
Last edited: 18/01/2019

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Other

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Katarzyna Okulicz-Kozaryn
Scientific

Institute of Psychiatry and Neurology
Sobieskiego 9
Warsaw
02-957
Poland

Study information

Primary study design	Interventional
Study design	Cluster randomised controlled trial
Secondary study design	Randomised controlled trial
Study type	Participant information sheet
Scientific title	Effectiveness of the Strengthening Families Program (SFP10-14) for reducing alcohol and drug misuse amongst youth in Poland: a randomised controlled trial
Study objectives	1. SFP10-14 will reduce alcohol and drug use / misuse amongst young people compared with controls 2. SFP10-14 will reduce behavioural and emotional problems amongst young people compared with controls 3. SFP10-14 will improve parenting compared with controls 4. SFP10-14 will improve parent-child relations compared with control
Ethics approval(s)	There is no formal ethics committee requirement for research projects funded by the Polish Bureau for Drug Prevention (the research funders), though there is an expectation in cases that any ethical issues are identified during the scientific peer review process organised by the funding agency.
Health condition(s) or problem(s) studied	Public Health
Intervention	The SFP1014 is a video based programme delivered by trained facilitators that includes parents/guardians and children learning together. The 7-week program is delivered over 7-sessions, with four optional booster sessions available several months later.
Intervention type	Other
Primary outcome measure(s)	1. Alcohol, cigarette and other drugs: age of first use, lifetime prevalence, 30-days (not other drugs) and 12-month prevalence 2. Alcohol use without parent permission 3. Drunkenness / binge drinking in past 30 days
Key secondary outcome measure(s)	1. General child management 2. Parent child affective quality 3. Aggressive and hostile behaviours in interactions 4. Intervention-targeted parenting behaviour scale 5. Index of aggressive and destructive conduct 6. Family aggressiveness 7. Family togetherness 8. Maternal support 9. Parental monitoring 10.Time spent with mother / father 11. Family rituals 12. Family life questionnaire 13. Truancy 14. School behaviour grades 15. Strengths and difficulties questionnaire
Completion date	31/03/2013

Eligibility

Participant type(s)	Patient
Age group	Child
Lower age limit	10 Years
Upper age limit	14 Years
Sex	All
Target sample size at registration	600
Key inclusion criteria	1. Families with one or more children aged 10-14 2. At least one parent and one child consents to participate
Key exclusion criteria	Does not meet inclusion criteria
Date of first enrolment	04/01/2010
Date of final enrolment	31/03/2013

Locations

Countries of recruitment

Poland

Study participating centre

Institute of Psychiatry and Neurology

Warsaw
02-957
Poland

Results and Publications

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

Study outputs

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	01/06/2017	18/01/2019	Yes	No
Protocol article	protocol	20/06/2012		Yes	No
Participant information sheet	Participant information sheet	11/11/2025	11/11/2025	No	Yes

Editorial Notes

18/01/2019: Publication reference added